5-Minute Clinical Consult

Hepatitis, Autoimmune

Hepatitis, Autoimmune was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.

To view this entire topic, please or purchase a subscription.

Explore 5-Minute Clinical Consult - view these FREE monographs:

5-Minute Clinical Consult

-- The first section of this topic is shown below --

Basics

Description

Autoimmune hepatitis (AIH) is a chronic inflammatory disorder of the liver of unknown etiology, characterized by interface hepatitis, hypergammaglobulinemia, and autoantibodies:

  • Clinical presentation can range from asymptomatic to acute, severe disease.
  • AIH is diagnosed based on clinical, histologic, biochemical, and immunologic criteria.

Epidemiology

Incidence
0.1–1.9/100,000/year in Caucasian populations. Lower incidence in Japan.

Prevalence
  • 11.6–16.9/100,000 in Europe
  • Females more affected than men for all types of AIH (3.6:1)
  • Most common in Caucasians of northern European descent
  • Bimodal age distribution for type I: Adolescents and adults in the 4th–6th decades are most at risk.
  • Type II is more often found in southern Europe vs. northern Europe, the US, or Japan. Primarily affects young females and children.

Risk Factors

  • Female sex
  • Triggers include medications, viruses (acute hepatitis A or B, Epstein-Barr)
  • Associated autoimmune conditions
Genetics
  • Associated with the complement allele C4AQO and with human leukocyte antigen (HLA) haplotypes B8, B14, DR3, DR4, and Dw3
  • Studies show associations between microsatellite markers on chromosomes 11 and 18 (D11S902 and D18S464) and type I AIH (1).

Pathophysiology

  • Hepatic damage results from cell-mediated immunologic attack:
    • HLA facilitates presentation to antigen-processing cells, which encourage cytotoxic T-cell production.
    • Cytotoxic T-lymphocytes infiltrate hepatic tissue, release cytokines, and destroy hepatocytes.
    • Chronic inflammation of the liver leads to fibrosis and eventually cirrhosis in advanced cases.
  • Acute fulminant inflammation can lead to acute liver failure in the absence of cirrhosis.
  • Type I (80% of cases): Circulating antismooth muscle antibodies (SMA) and/or antinuclear antibodies (ANA)
  • Type II: Antibodies to liver/kidney microsome type 1 (anti-LKM-1):
  • Type III (least well-established type): Soluble liver antigen/liver pancreas antigen (SLA/LP); clinically identical to type I, but with different antibody profile

Etiology

Idiopathic

Commonly Associated Conditions

  • Type 1 diabetes mellitus
  • Autoimmune thyroiditis
  • Immune-mediated hemolytic anemia
  • Idiopathic thrombocytopenic purpura
  • Celiac sprue
  • Ulcerative colitis
  • Vitiligo
  • Rheumatoid arthritis
  • Primary biliary cirrhosis and primary sclerosing cholangitis occasionally overlap with AIH (1).

-- To view the remaining sections of this topic, please or purchase a subscription --